Sudeep Pharma Other Announcement

Earnings Call

Sudeep Pharma Earnings Call Transcript: Key Takeaways

Sudeep Pharma delivered record quarterly revenue led by its Pharma Food Nutrition (PFN) segment, though specialty ingredients face short-term headwinds from the pause of a government rice program.

Earnings Call

Sudeep Pharma Investor Presentation: Key Takeaways

Q2FY27 revenue Rs196.7cr (+21% YoY), record EBITDA Rs73.2cr (+32%, 37.2% margin), PAT Rs51.8cr (+11%). Battery-materials pivot and Nandesari FDA approval are the strategic highlights.

Financial Results

Sudeep Pharma Q2 FY27 Results: Net Profit ₹51.8 Cr, Up 10.7% YoY

Sudeep Pharma Ltd reported revenue from operations of ₹196.7 Cr (+20.9% YoY) and net profit of ₹51.8 Cr (+10.7% YoY) for Q2 FY27.

Key figure

Net profit ₹51.8 Cr · +10.7% YoY

Capacity ExpansionAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudeep Pharma Capacity Expansion

Sudeep Pharma received FDA approval for its new 51,200 MT greenfield plant at Nandesari, Gujarat. Commercial operations are expected to commence in H2 FY27 following customer qualification.

manufacturing capacity

51200 MT

Board Meeting Date

Sudeep Pharma Board Meeting Date

Sudeep Pharma has scheduled its Board meeting for 28 October 2026 to approve Q1 and H1 FY27 financial results. No results or monetary figures are disclosed in this intimation.

Management Change

Sudeep Pharma Management Change

Mr. Sendhil Pani has ceased to be a Senior Management Personnel of Sudeep Pharma Ltd effective October 2, 2026. This follows the completion of his contractual arrangements.

Other AnnouncementSTL Networks Ltd STLNETWORK

STL Networks Other Announcement

The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.

Other AnnouncementHEG Advanced Materials Ltd HEGAM

HEG Advanced Materials Other Announcement

HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.

Other AnnouncementSanofi India Ltd SANOFI

Sanofi India Other Announcement

Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.

Other AnnouncementVisaka Industries Ltd VISAKAIND

Visaka Industries Other Announcement

Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.

Other AnnouncementArvaya Healthcare Ltd BIJHANS

Arvaya Healthcare Other Announcement

Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.

Other AnnouncementAYM Syntex Ltd AYMSYNTEX

AYM Syntex Other Announcement

AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.

Execution

Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM